Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Non Operating Income: 2023-2025

Historic Non Operating Income for CG Oncology (CGON) over the last 3 years, with Sep 2025 value amounting to $7.3 million.

  • CG Oncology's Non Operating Income fell 7.21% to $7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.6 million, marking a year-over-year increase of 23.57%. This contributed to the annual value of $26.6 million for FY2024, which is 289.17% up from last year.
  • CG Oncology's Non Operating Income amounted to $7.3 million in Q3 2025, which was up 0.08% from $7.3 million recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Non Operating Income ranged from a high of $7.9 million in Q3 2024 and a low of $713,000 during Q2 2023.
  • Over the past 3 years, CG Oncology's median Non Operating Income value was $6.3 million (recorded in 2024), while the average stood at $5.1 million.
  • Per our database at Business Quant, CG Oncology's Non Operating Income soared by 874.89% in 2024 and then decreased by 7.21% in 2025.
  • CG Oncology's Non Operating Income (Quarterly) stood at $2.8 million in 2023, then surged by 123.25% to $6.3 million in 2024, then dropped by 7.21% to $7.3 million in 2025.
  • Its Non Operating Income stands at $7.3 million for Q3 2025, versus $7.3 million for Q2 2025 and $7.8 million for Q1 2025.